Daniel Javitt - 16 Nov 2022 Form 4 Insider Report for NRX Pharmaceuticals, Inc. (NRXP)

Role
10%+ Owner
Signature
Daniel Javitt
Issuer symbol
NRXP
Transactions as of
16 Nov 2022
Transactions value $
-$171,138
Form type
4
Date filed
18 Nov 2022, 18:05
Previous filing
15 Nov 2022
Next filing
01 Dec 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NRXP common stock Sale -$136K -134K -1.36% $1.02 9.69M 16 Nov 2022 by Glytech LLC F1, F2
transaction NRXP common stock Sale -$34.7K -33K -0.34% $1.05 9.66M 17 Nov 2022 by Glytech LLC F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Sale was pursuant to the terms of a 10b5-1 trading plan established on June 13, 2022.
F2 Held by Glytech LLC of which the Reporting Person is the sole owner.